Drug intelligence / Profile preview

zinc sulfate

Development stage: Approved
Lead developer: H & W Labs
Modality: Small Molecules
Administration: Oral

Overview

H-Zinc-Plus is an oral dietary supplement containing zinc sulfate, developed by H & W Labs. Zinc is an essential trace mineral that serves as a cofactor for more than 300 enzymes involved in critical cellular processes, including DNA and RNA synthesis, protein metabolism, cell division, and tissue repair. H-Zinc-Plus is primarily used to treat or prevent zinc deficiency, support immune function, and manage acute diarrhea, particularly in pediatric populations.

Brand names: H-ZINC-PLUS
Other names: zinc sulfate heptahydratezinc sulphatezinc sulphate monohydrate

Targets

CaSR (Extracellular calcium-sensing receptor)KCNQ1 (Potassium voltage-gated channel subfamily KQT member 1)

Beyond the preview

Go deeper on zinc sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on zinc sulfate.